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Editorial on the Research Topic
Dementia, Frailty and Aging
Population aging is both a worldwide success story and a worldwide health conundrum, with the
increasing age of populations around the world leading to unprecedented challenges (1). According
to the United Nations report on World Population Prospects (2017), there is an estimated 962
million people aged 60 years and above who comprise 13% of the global population (2). The
beginning of the twenty-first century has seen health systems worldwide struggling to deliver
quality healthcare amidst challenges posed by aging populations (3). Traditional medicine and
models of care have been premised on the evaluation and treatment of standalone and usually
acute diseases occurring in relatively younger individuals. This contrasts with the current reality of
multiple, interacting, and often chronic conditions affecting older persons. It is thus necessary to
disentangle the pathophysiological mechanisms, clinical manifestations, and inter-relationships of
age-related conditions in order to personalize clinical interventions and realign health systems to
better address the unmet needs of frail older persons (4, 5).
Against this backdrop, frailty and dementia have emerged as priority areas in both research
and clinical settings due to their high prevalence, impact on the individual’s quality of life, and
public health impact (6–8). These conditions aptly reflect the complexity of age-related pathological
conditions, causally underpinned by a myriad of heterogeneous, interacting, and often unclear
pathophysiological processes. Indeed, a hallmark of both conditions is the inherent difficulty
in differentiating the effects of the normal aging process from the eventual pathophysiological
deviations of the underlying disease (9, 10). Their occurrence and trajectories over time are strongly
affected by a wide array of factors and determinants that are not confined to single biological
systems and/or health domains (10). Moreover, environment and social factors also substantially
influence the definition of different phenotypes. This raises the clarion call for a broader,
integrated, and holistic approach that is able to more adequately capture the biological, clinical,
and psychosocial complexities of frailty and dementia, thus paving the way for improvement in the
consequent outcomes (11–13).
The present Research Topic represents a timely addition to the burgeoning body of evidence
which aims to provide fresh perspectives in our understanding of the frailty and dementia
phenomena occurring with aging. An area of particular interest is the emerging construct of
cognitive frailty (CF), which is designed to operatively capture the co-existence of frailty and
cognitive impairment in the absence of dementia (14). Using amodified version of the IANA/IAGG
criteria (15), Ma et al. reported a 2.7% prevalence of CF in a Chinese older population. Older
persons, women, and people living in rural areas were found to be at higher risk of CF.
Corroborating the recommendations of the Lancet Commission report (7), depression and hearing
impairment were independently associated with CF in elderly individuals with physical frailty.
The study by Nyunt et al. explored the physical frailty phenotype in mild cognitive impairment
(MCI). When compared with participants with “normal high cognition,” there was a higher
prevalence of frailty and pre-frailty attributable to low lean mass, slow gait speed, or balance
and gait impairment. In their 5-year observational study of 91 subjects with amnestic MCI,
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Trebbastoni et al. also noted that frailty was associated with
increased risk of conversion to Alzheimer’s dementia, even in
those with high baseline level of cognitive performance.
Four papers in this Research Topic shed further insights
to illuminate the knowledge gap in our understanding of the
interface between cognitive and physical domains. In their study
of 269 elderly individuals with subjective memory complaints,
Hooper et al. did not find any significant cross-sectional
associations between fatigue and Aβ load. However, sensitivity
analysis revealed a weak association with increased Aβ in the
hippocampus in subjects with MCI, thereby providing indirect
support for the construct of CF at the early stages of Alzheimer’s
disease. Chhetri et al. proposed the motoric cognitive risk (MCR)
syndrome, characterized by the simultaneous presence of gait
disturbances and memory complaints in older adults, as a
means to examine the close interactions between cognitive and
physical domains and identify individuals at risk of dementia and
other age-related adverse outcomes. By summarizing the existing
evidence from both human and animal models, Bellelli et al.
highlighted the multiple common pathophysiologic mechanisms
and pathways of delirium and frailty, to lay out the case for
delirium as the cognitive harbinger of a state of frailty in the
context of an acute clinical event. This opens the door for further
studies to examine the contribution of physical frailty to adverse
outcomes in delirium, and conversely, the deleterious impact of
delirium on physical frailty (16). Using the examples of frailty
and MCI, the review by Canevelli et al. challenged the widely-
held assumptions of these entities as unequivocally prodromal
stages of a future disease state by providing a timely reminder
of our incomplete understanding of the transitions of clinical at-
risk conditions and their potential for clinical improvement and
spontaneous reversion.
Dementia is a devastating and debilitating illness that has
far-reaching public health, social and economic ramifications.
Therefore, the Research Topic submissions also covered
pertinent areas in dementia such as caregiving and diagnosis. To
keep pace with the projected exponential rise in dementia, it is
imperative that we tap upon the “invisible workforce” of family
caregivers and understand the factors that predispose to caregiver
burden (17). Li et al. confirmed the existence of the unique “worry
about performance” (WaP) burden in the multidimensionality of
caregiver burden beyond role and personal strain. Unlike other
factors, WaP was significantly reported even in early cognitive
impairment, suggesting its potential as a possible target for
interventions aimed at improving self-efficacy among caregivers
in the milder stages of burden (18). In their study examining
the rapidly expanding group of caregivers of dementia in oldest-
old (CDOO), Win et al. reported these were mainly older adult
children who experienced significant role and personal strain
rather thanWaPwhile caring for their oldest-old familymembers
with more impaired cognitive and physical function. To address
the challenges of under-detection of dementia in the primary care
setting, Teixeira et al. described a potentially scalable multi-stage
strategy for community detection that involved initial screening
by health professionals to identify at-risk individuals for more
comprehensive evaluation. With the recent release of the NIA-
AA Research Framework directed toward a biological definition
of Alzheimer’s disease (19), the real-world study of geriatrics
outpatients by Dolci et al. highlighted the discrepancy between
clinical diagnosis of Alzheimer’s disease with cerebrospinal fluid
and neuroimaging biomarkers, thereby reiterating the caution
against premature and inappropriate usage of biomarker-based
research frameworks in general medical practice.
Novel approaches are also suggested in this Research Topic.
Reviving a 100-year old idea about a possible role played by
gut microbiota in modulating brain morphology and function
across the life-course (20), Calvani et al. proposed the fascinating
concept of the “second brain aging” which links age-related
changes in the gut mircrobiota to neurodegeneration and
related conditions (including depression, Alzheimer’s disease,
and Parkinson’s disease). This raises the tantalizing prospect of
developing interventions that target the gut microbiota as part of
a comprehensive strategy in dementia prevention and treatment.
Yatawara et al. explicated the cognitive-anatomical basis of
getting lost behavior in patients with mild Alzheimer’s disease.
They reported that the top-down modulation deficit is localized
to the medial temporal lobe and did not follow the typical
mechanism in healthy aging, highlighting the need to target both
working memory and visuospatial deficits simultaneously. Lastly,
the thoughtful review by Lenca et al. explored the potential of
harnessing big data approaches to improve current preventive
and predictive models in dementia care and research (e.g.,
enabling earlier diagnosis, optimizing resource allocation, and
delivering individualized treatments tailored to patients). The
authors highlighted technical, scientific, ethical, and regulatory
challenges and proposed the need for multi-level integrative
approaches to chart the route ahead for research, ethics, and
policy.
As guest editors for this research topic on frailty, dementia,
and aging, we are delighted to commend to you the collection
of 14 articles as an important contribution to “evidence-balanced
medicine” in the real world of frail older persons (21).
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